Actions by the FDA in our ongoing response to the COVID-19 pandemic since our last MCMi email update include:
- September 15, 2020: Daily Roundup on FDA issuance of two warning letters in its ongoing response to the COVID-19 pandemic
- September 15, 2020: FDA Publishes Comparative Performance Data for COVID-19 Molecular Diagnostic Tests
- September 14, 2020: FDA and global partners to analyze coronavirus samples, in an effort to help inform development of SARS-COV-2 diagnostics, vaccines, and therapeutics
- September 11, 2020: The FDA’s Scientific and Regulatory Oversight of Vaccines is Vital to Public Health, by FDA Commissioner Stephen M. Hahn, MD, and Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research
|
No hay comentarios:
Publicar un comentario